Hypothesis: Bipolar Illness with Complaints of Chronic Musculoskeletal Pain Is a Form of Pseudofibromyalgia

Seminars in Arthritis and Rheumatism

Volumn 37, Issue 4, 2008, Pages 256-259

  Wallace, Daniel J ^a   Gotto, Jennifer ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

bipolar illness; fibromyalgia; pain

Indexed keywords

NEUROTRANSMITTER;

ADULT; ARTICLE; BIPOLAR DISORDER; CHRONIC PAIN; CONSULTATION; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDLINE; MENTAL PATIENT; MUSCULOSKELETAL PAIN; PRIORITY JOURNAL; PSEUDOFIBROMYALGIA; PSYCHIATRIC DIAGNOSIS;

BIPOLAR DISORDER; DIAGNOSTIC ERRORS; FIBROMYALGIA; HUMANS; PAIN; PREVALENCE;

EID: 38349191711     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2007.04.008     Document Type: Article

References (20)

1. Wallace D.J., and Wallace J.B. Fibromyalgia: an essential guide for patients and their families (2003), Oxford Univ. Press, New York/London 1-196
2. Arnold L.M., Hudson J.I., Keck P.E., and Auchenbach M.B. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67 (2006) 1219-1225
3. Aaron L.A., Bradley L.A., Alarcon G.S., Alexander R.W., Triara-Alexander M., Martin M.L., et al. Psychiatric diagnoses in patients with fibromyalgia are related to health-care seeking behavior rather than to illness. Arthritis Rheum 39 (1996) 436-445
4. Goldenberg D.L., Kaplan K., and Mossey C.J. Is there a specific personality trait associated with fibromyalgia?. Arthritis Rheum 38 (1995) S247
5. Ohayon M.M. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med 165 (2005) 35-41
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, Washington, DC (1995) 350-366
7. Furlan A.D., Sandoval J.A., Mailis-Gagnon A., and Trunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J 23 (2006) 174 1589-94
8. Yunus M.B. The concept of central sensitivity syndromes. In: Wallace D.J., and Clauw D.J. (Eds). Fibromyalgia and Other Central Pain Syndromes (2005), Lippincott, Williams & Wilkins, Philadelphia 29-44
9. Clauw D.J., and Crofford L.J. Chronic widespread pain: what we know and what we need to know. Best Prac Res Clin Rheumatol 17 (2003) 685-701
10. Russell J. Neurotransmitters, cytokines, hormones and the immune system in chronic nonneuropathic pain. In: Wallace D.J., and Clauw D.J. (Eds). Fibromyalgia and Other Central Pain Syndromes (2005), Lippincott, Williams& Wilkins, Philadelphia 63-80
11. Staud R. The neurobiology of chronic musculoskeletal pain. In: Wallace D.J., and Clauw D.J. (Eds). Fibromyalgia and Other Central Pain Syndromes (2005), Lippincott, Williams & Wilkins, Philadelphia 45-62
12. Russell L.J., Orr M.D., Littman B., Vipraio G.A., Alboukrek D., Michalek J.E., et al. Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 37 (1994) 1593-1601
13. Staud R., Vierck C.J., Cannon R.L., Mauderti A.P., and Price D.D. Abnormal sensitization and temporal summation of second pain (wind up) in patients with fibromyalgia syndrome. Pain 91 (2001) 165-175
14. Wallace D.J. Fibromyalgia and the neurobiology of sleep. In: Pandi-Perumal S.R., Ruoti R.R., and Kramer M. (Eds). Sleep and Psychosomatic Medicine (2007), Informa Healthcare, Abington, United Kingdom 249-259
15. Stovall J. Bipolar disorder, Up to Date (2006) version 14.2
16. Benabarre A., Vieta E., Martin F., Lomena F., Martinez-Aran A., Colon F., et al. Clinical value of 99m-Tc-HMPAO SPECT in depressed bipolar I patients. Psychiatry Res 132 (2004) 285-289
17. Post R.M., Speer A.M., Hourgh C.J., and Xing G. Neurobiology of bipolar illness: implications for future study and therapeutics. Ann Clin Psychiatry 15 (2003) 85-94
18. Yunus M.B., Young C.S., Saeed S.A., Mountz J.M., and Aldag J.C. Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis Rheum 51 (2004) 313-318
19. Lieb K., Treffurth Y., Berger M., and Fiebich B.L. Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?. Neuropsychobiology 45 suppl 1 (2002) 2-6
20. Berrettini W.H., Robinow D.R., Nurnberger N., Simmons-Alling S., Post R.M., and Gershon E.S. CSF substance P immunoreactivity in affective disorders. Biol Psychiatry 20 (1985) 965-970